The recent settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is a welcome ...

Mizuho Securities analyst Salim Syed maintained a bullish stance on BridgeBio Pharma, Inc. (NASDAQ:BBIO)’s stock, providing a “Buy” rating. As per the analyst, the current market consensus ...

(RTTNews) - Zentalis Pharmaceuticals, Inc. (ZNTL) has experienced a significant drop of 24.38 percent in its stock value following Tuesday's announcement of a major workforce reduction. Currently ...

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Vertex Pharmaceuticals wasn’t one of them. The 10 stocks that ...

Members of the Sackler family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion to settle lawsuits over the toll of the powerful prescription ...

New York Attorney General Letitia James announced Thursday a new $7.5 billion settlement with Purdue Pharmaceuticals and the Sackler Family for their role in the ongoing US opioid crisis, with the ...

Novo Nordisk declined the most (36.6%). (See the last pharma stock roundup here: Pharma Stock Roundup: J&J’s ITCI Buyout, LLY’s Weak Q4 Preliminary Sales) Watch this space for SNY, ABBV ...

NEW YORK (Reuters) - Purdue Pharma said on Friday it needs more time to build support for a new $7.4 billion settlement that could complete the company's years-long effort to resolve thousands of ...

The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end ...